Health Sciences Centre
Winnipeg, Manitoba, R3E 3P4, Canada
NCT Number: NCT00354471
This study will evaluate the safety, efficacy , quality of life and patient satisfaction of uterine artery embolization for the treatment of symptomatic uterine fibroids. It will provide useful information in the development od guidelines in patient selection, procedural management and subsequent follow up.
Looking for future studies?
Notify Me18 year–60 year
Female
Observational
Winnipeg, Manitoba, R3E 3P4, Canada
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Manitoba
Other
Short and Long Term Outcomes of Uterine Artery Embolization.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01865929
Cervical Dysplasia, Female Urogenital Diseases
Lund, Sweden
View Trial DetailsNCT03317795
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Jacksonville, Florida, United States
View Trial DetailsNCT00731341
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amsterdam, Netherlands
View Trial DetailsNCT01992718
Adenomyosis, Female Urogenital Diseases
Ann Arbor, Michigan, United States
View Trial Details